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Background: Leptospirosis is a global zoonosis caused by pathogenic Leptospira. The non-specific clinical signs and
symptoms of leptospirosis lead to its misdiagnosis. To date, there is still no reliable rapid test kit that can accurately
diagnose leptospirosis at bedside or in field. In this research, with the ultimate goal of formulating a rapid and
accurate diagnostic tool for leptospirosis, we aimed to identify leptospiral proteins excreted in urine of infected
hamsters, which are thought to mimic Weil’s disease.
Results: Hamsters were subcutaneously infected with leptospires, and the general attributes of urine as well as the
proteins excreted in it were examined. Some leptospiral proteins were found to be excreted in the urine from the
early phase of infection. The most important finding of this study was the detection of the lipid-metabolizing enzyme,
3-hydroxyacyl-CoA dehydrogenase (HADH), before the onset of illness, when leptospires were not yet detected in the
urine of infected hamsters.
Conclusions: This is the first report on the detection of leptospiral HADH in the host urine, which may be a possible
candidate leptospiral antigen that can be used in the early diagnosis of human and animal leptospirosis.
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Leptospirosis is a global zoonosis caused by the pathogenic
Leptospira spp. Outbreaks of leptospirosis usually occur
after heavy rains followed by floods in tropical and sub-
tropical developing countries, and recreational activities in
developed countries [1,2]. The genus Leptospira is com-
prised of 21 species and more than 300 serovars. Animals
may become maintenance hosts of some serovars or inci-
dental hosts of others [3]. Infection of accidental hosts
may cause severe or fatal disease. Wild rats, dogs, buffa-
loes, horses, and pigs are known to contract the disease
and the surviving animals maintain the organisms in their
kidneys. Infected animal urine contains leptospires, which
may contaminate the environment once excreted, becom-
ing a new source of infection for humans and susceptible* Correspondence: tsegawa@bact.med.kyushu-u.ac.jp
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unless otherwise stated.animals. Infection of humans or animals occurs when lepto-
spires penetrate both normal and injured skin and mucosal
surfaces after direct contact with the urine of infected ani-
mals or indirectly from contaminated environments [1,4].
Signs and symptoms of human leptospirosis are usually
mild, however, 5% of cases develop the severe form pre-
senting jaundice, renal failure, and pulmonary hemorrhage
[1,2,4-6]. This zoonotic infection is treatable but its early
phase has clinical presentations similar to many other
diseases thereby complicating its clinical diagnosis. Early
diagnosis of leptospirosis is essential to prevent progres-
sion to the severe stage because antibiotic treatment is
effective when it is initiated early in the course of the
disease.
The gold standards for diagnosis of leptospirosis are
isolation of Leptospira by culture from blood, urine or
tissues of infected hosts and the microscopic agglutination
test (MAT) to detect antibody. However, results of these
diagnostic methods can only be evaluated more thanl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Survival of infected hamsters and sequential change
of general urinary conditions during Leptospira infection. (A)
Survival rate of infected hamsters and Leptospira-positivity ratio of
the urine culture were checked every day. Hamsters were infected
with 103 leptospires and urine was collected every day from pre-
infection to just before death. Chemical analysis of hamster urine
was done using urinalysis paper and absorbance was also measured
at 600 nm. Infected hamsters became moribund from the eighth
day post infection. Leptospires were recovered from the urine from
the seventh day after infection. Three independent experiments
were done (n = 10) and the sum of the survival rate of the 10
hamsters are shown. (B and C) Urinary pH (B) and absorbance (C)
changed after the seventh day. Hamster infection experiments were
repeated three times. The sum of the turbidity and pH values were
taken and the average (±SD) are shown (n = 10). *: p < 0.05,
**: p < 0.01.
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expertise is needed in order to perform the culture and
MAT. In attempts to replace these two methods, other
diagnostic methods were developed such as enzyme-linked
immunosorbent assay (ELISA) [7], polymerase chain reac-
tion (PCR) [8-11], and so on [12-16]. However, these are
not simple or rapid tests that can be used at bedside
[1,2,4,17] and sophisticated equipment is needed in order
to perform PCR. In addition, with the exception of PCR,
the sensitivities of the other assays are not satisfactory, es-
pecially during the acute phase of infection [18]. At present
there is a lack of available kits that are able to detect lepto-
spiral antigens in patient samples such as urine. Further-
more, there is also a need for simple and rapid leptospirosis
diagnostic kits that are cheap, highly sensitive, highly
specific, and can easily be used at bedside or in the field.
Urine is expected to be the best sample for diagnosis,
because the urine of leptospirosis patients contains lep-
tospiral antigens and can be collected easily [19-26].
Urine of patients has often been used for culture of
Leptospira, however, more information on proteins can
be obtained from urine [27].
The golden Syrian hamster is susceptible to Leptospira
infection, and acute leptospirosis in the hamster model
reproduces the severe form of human leptospirosis, and
is therefore useful in evaluating diagnostic methods [28].
In this study, we analyzed the characteristics and protein
components of Leptospira-infected hamster urine in
order to identify proteins that may be possibly used in
developing rapid and accurate leptospiral antigen diag-
nostic kits. We identified a leptospiral protein, 3-
hydroxyacyl-CoA dehydrogenase (HADH), which was
found to be excreted in the urine of hamsters during the
early phase of infection.
Results
Changes in urine characteristics of hamsters during
Leptospira infection
Hamsters were subcutaneously infected with 103 lepto-
spires (strain K64), and their urine was collected daily in
metabolic chambers for 6 h. All infected hamsters became
markedly sick after the seventh day showing decreased
mobility and body weight, ruffled fur, and decreased food
and water intake, and became moribund from the eighth
day post infection (Figure 1A). We confirmed that the
cause of death was leptospirosis because leptospires were
isolated from the blood, urine, and organs (lungs, livers,
kidneys, spleens, and brains) of moribund hamsters.
Normal hamster urine was alkaline (Figure 1B) and milky
(Figure 1C). However, it became acidic (Figure 1B) and
clear (Figure 1C) after the seventh day of infection. Urine
culture was negative for leptospires until the sixth day, but
became positive from the seventh day post infection
(Figure 1A). Using urinalysis strips, we also found that thelevels of glucose, specific gravity, blood, protein and biliru-
bin increased at the same time, whereas the levels of urobi-
linogen, nitrite, leukocyte and ketone did not change.
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increased to 300 mg/dl on the seventh day post infection.
Changes in hamster urinary proteins during leptospiral
infection
The hamster urine was collected daily from pre-infection
to just before death and the protein compositions were
compared using SDS-PAGE. Until the sixth day post
infection, urinary protein compositions were almost the
same as that of pre-infection. Significant change was
observed after 7 days of infection, particularly an increase
in the density of approximately 66 kDa protein which is
thought to be albumin (Figure 2A).
For detecting leptospiral proteins in hamster urine, we
performed immunoblotting with rabbit polyclonal anti-
body against L. interrogans serovar Manilae. Three bands
with sizes of 65, 52, and 30 kDa were detected in the post-
infection urine (Figure 2B). These bands were already
detected during the early phase of post-infection. During
this phase, the hamster appeared healthy and no viable
leptospires were recovered from the urine. 26 kDa protein
was detected in urine before and during infection so this
protein was not a result of infection.
Comparative analysis of urinary protein composition
before and after Leptospira infection by using two
dimensional electrophoresis (2-DE) and immunoblotting
As shown in the results of SDS-PAGE (Figure 2A), the
composition of urinary proteins was found to have
changed drastically after the seventh day of infection.Figure 2 SDS-PAGE and immunoblotting of hamster urine protein du
proteins were compared according to infection periods. Hamster urine was
was mixed for each infection period. The protein content of each sample w
staining. (B) The anti-L. interrogans pAb recognized leptospiral proteins in infe
repeated three times, and the representative data are shown in this figure.To compare these components in detail, the urinary
proteins of pre-infection and seventh day of infection
were analyzed by 2-DE (Figure 3). The 2-DE pattern of
urinary proteins changed after Leptospira infection. It
was found that the level of approximately 66 kDa pro-
tein in the urine significantly increased on the seventh
day (Figure 3A and B). By immunoblotting using anti-L.
interrogans pAb, the 60 kDa spots were detected (Fig-
ure 3D, arrow). However, spots with other sizes were
not detected in hamster urine (Figure 3D). 2-DE ana-
lysis were also done for urine samples at 3–4 days in-
fection however the protein pattern was found to be
the same as pre-infection urine samples and further
analysis by immunoblot was also unable to detect any
protein spots (data not shown).
Proteins with increased levels after Leptospira infection
A total of 29 protein spots that had increased density after
infection (Figure 3B) were selected and analyzed by LC/
MS/MS analysis. Database analysis showed that these
urinary proteins were albumin, alpha-1-antitrypsin, alpha-
1-inhibitor III, angiotensinogen, apolipoprotein A-I, ceru-
loplasmin, haptoglobin, pancreatic trypsin 1, pregnancy
protein 60 kDa, protease serine 1, transferrin, transthyre-
tin, AMBP protein, vitamin D-binding protein and Cu/Zn
superoxide dismutase (Table 1). Most of these proteins
were serum proteins, which are usually detected in the
urine of patients with renal failure. It is noteworthy that
some of the leptospiral proteins were also identified as
ABC transporter, 3-hydroxyacyl-CoA dehydrogenasering Leptospira infection. (A) Compositions of hamster urinary
collected and prepared for SDS-PAGE. The urine of three hamsters
as 5 μg. After separation with SDS-PAGE, the gel was stained by silver
cted-hamster urine by immunoblotting. These experiments were
Figure 3 2-DE analysis of normal and infected hamsters urine. Urinary protein patterns of hamsters were compared by 2-DE analysis; (A, C) before
infection; (B, D) 7–8 days post-infection. The urine of three hamsters was mixed for each infection period. The total protein content of each sample
was 20 μg. Each pattern of urinary protein was separated by pI (4–7), 12.5% acrylamide gel, and subsequently silver staining (A, B), or immunoblotting
with anti-L. interrogans pAb was done (C, D). Arrows (D) show spots of 60 kDa that reacted with the polyclonal antibody at 7–8 days post-infection.
Each experiment was repeated three times, and the representative data are shown in this figure.
Table 1 List of hamster proteins excreted in urine that had increased levels of expression during infection
Spot no. Accession no.† Protein annotation MW (kDa) pI Urinary marker of diseases (Reference)
28 gi:110347564 ceruloplasmin isoform b [Mus musculus] 121872 5.53 Acute renal transplant rejection [29,30]
29 gi:83816939 alpha-1-inhibitor III [Rattus norvegicus] 165038 5.7 No reports
30, 32, 33, 38 gi:58585560 albumin [Microtus fortis fortis] 70261 5.91 Glomerular disease [31,32],
Diabetes mellitus type 2 [33]
31 gi:17046471 transferrin [Mus musculus] 78794 6.92 Glomerular disease [31,32]
34 gi:68052028 Alpha-1-antitrypsin precursor 46019 5.55 Glomerular disease [32]
35 gi:191388 pregnancy protein 60 kDa 47574 8.53 No reports
36 gi:19705570 angiotensinogen [Rattus norvegicus] 52177 5.37 Chronic kidney disease [34]
37 gi:193446 vitamin D-binding protein [Mus musculus] 54647 5.26 Glomerular disease [31,32]
39-41 gi:41019123 Haptoglobin precursor 39090 5.76 Glomerular disease [31,32],
Diabetes mellitus type 2 [33]
42 gi:2497695 AMBP protein precursor 39669 5.87 Diabetes mellitus type 2 [33,35]
43-45, 48 gi:62899898 Apolipoprotein A-I precursor 30720 5.86 Glomerular disease [36]
46, 51, 52 gi:6981420 pancreatic trypsin 1 [Rattus norvegicus] 26627 4.71 Pancreatitis [31]
47, 49 gi:16716569 protease, serine, 1 [Mus musculus] 26802 4.75 No reports
50, 53, 54 gi:6981684 transthyretin [Rattus norvegicus] 15852 5.77 Glomerular disease [31,32],
Diabetes mellitus type 2 [33]
55 gi:226471 Cu/Zn superoxide dismutase 15923 6.03 Endemic nephropathy [37]
†http://www.ncbi.nlm.nih.gov/protein/.
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Figure 4 SDS-PAGE and immunoblotting of recombinant leptospiral
HADH. (A) The rHADH with His-tag was produced by E. coli and purified
by cobalt resin. In total, 1 μg of the protein was run by SDS-PAGE and
CBB staining. (B) Anti-His-tag antibody and (C) anti-L. interrogans pAb
detected the protein. Sharp signs indicate recombinant protein bands of
52 kDa. These experiments were repeated three times, and the
representative data are shown in this figure.
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proteins in the urine (Table 2).
Identification of HADH in hamster urine
As mentioned in the previous section, candidate lepto-
spiral proteins in urine were selected based on the results
of LC/MS/MS analysis. In order to identify leptospiral
proteins that are excreted in hamster urine during infec-
tion, recombinant proteins for each selected protein were
made. The proteins were screened by immunoblotting
with anti-L. interrogans pAb. Among them, only HADH
reacted to the antibody. The amino acid sequence of
HADH are shown in the Additional file 1: Table S1 and
had a coverage of 27%. The rHADH was purified with
TALON® Metal Affinity Resin (Clontech) and its expres-
sion was confirmed with coomassie brilliant blue (CBB)
staining (Figure 4A) and immunoblotting by anti-His (C-
term) antibody (Figure 4B). The anti-L. interrogans pAb
also recognized the rHADH (Figure 4C).
Detection of HADH in infected hamster urine with antiserum
We produced anti-rHADH antiserum in rabbits, and
examined its reactivity to rHADH by immunoblotting.
The rabbit antiserum recognized the recombinant protein
(data not shown). We then performed immunoblotting of
urine samples as in Figure 2B and the antiserum reacted
with the post-infection samples (Figure 5A). The reacted
protein increased after the seventh day of infection
(Figure 5B). The protein was found to be excreted in the
urine before leptospires were shed (Figure 1A).
Discussion
We confirmed, by immunoblotting, that several leptospiral
proteins were shed in the urine of infected hamsters from
the early phase of infection (Figure 2B). On the 7-8th day
post-infection, the amount of 52 and 65 kDa leptospiral an-
tigens increased. It was suggested that the proportion of
30 kDa proteins decreased because of rich albumin passing
into the urine. Furthermore, we performed 2-DE for aTable 2 List of leptospiral proteins excreted in hamster urine
Spot no. Accession no.† Locus tag* Protein annotation
32 gi:45599159 LIC10012 conserved hypothetic
gi:45599713 LIC10580 ABC transporter, atp-
gi:45601755 LIC12676 conserved hypothetic
gi:45602095 LIC13023 conserved hypothetic
gi:45602258 LIC13191 conserved hypothetic
gi:45602297 LIC13229 conserved hypothetic
gi:45602365 LIC13300 3-hydroxyacyl-CoA de
gi:45602427 LIC13362 chloride channel
†http://www.ncbi.nlm.nih.gov/protein/.
*http://aeg.lbi.ic.unicamp.br/world/lic/.
#The proteins were predicted with PSORTb (http://www.psort.org/psortb/).detailed examination of protein components. Patterns of
urinary proteins were different between pre-infection and
after the seventh day of infection. As mentioned earlier,
the infected hamster urine consisted mostly of albumin,
consequently we determined proteins that had increased
expression. In 2-DE-immunoblotting, 60 kDa proteins
were detected by anti-L. interrogans pAb (Figure 3D).
However, though proteins with 52 and 30 kDa molecular
weights were detected in SDS-PAGE-immunoblotting
(Figure 2B), they were not found by 2-DE-immunoblotting
(Figure 3D). This may be because the two proteins were
diluted in 2-DE gel during pI separation or had specific pI
outside 4–7. From the amino acid sequence, molecular
weight of HADH is 52 kDa and this supports the probabil-
ity that the 52 kDa band in immunoblotting of urine
(Figure 2B), recombinant HADH study (Figure 4), and
dilution experiments of urine (Figure 5) is leptospiral
HADH. However in 2-DE-immunoblotting analysis, anti-during Leptospira infection
MW (kDa) pI Predicted location#
al protein 61792 9.27 Unknown
binding protein 71297 9.3 Cytoplasmic membrane
al protein 76551 5.75 Cytoplasm
al protein 51182 8.23 Cytoplasm
al protein 65453 6.51 Cytoplasm
al protein 68742 9.21 Unknown
hydrogenase 47865 8.65 Cytoplasm
67352 8.07 Cytoplasmic membrane
Figure 5 Immunoblotting of infected hamster urine by anti-HADH antisera. (A) Rabbit anti-rHADH serum was able to detect the 52 kDa
protein (*) in the urine of infected hamsters (n = 3). Each lane contained 5 μg of protein. (B) It was revealed, by serial dilution of urine, that HADH
increased in the said specimen during the seventh day post infection. These experiments were repeated three times, and the representative data
are shown in this figure.
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is revealed as leptospiral HADH by LC/MS/MS. Molecular
weight shift like this (from 52 to 60 kDa) is sometimes
observed in these kinds of experiments, and HADH was
included in 60 kDa proteins in the 2-DE- immunoblotting
(Figure 3D).
The most significant finding in our study was the detec-
tion in infected hamster urine of leptospiral protein
LIC13300, which is 3-hydroxyacyl-CoA dehydrogenase
(HADH) and is one of the intracellular enzyme proteins.
This protein is classified as an oxidoreductase in fatty acid
metabolic processes. It specifically catalyzes the third step
of beta oxidation. Long-chain fatty acids are utilized by
Leptospira as the sole carbon source and are metabolized
by beta-oxidation. Therefore, a large amount of HADH
may be produced intracellularly and released to get
carbons and energy by oxidizing free fatty acid.
We produced rabbit antiserum against recombinant lep-
tospiral HADH to detect the protein in infected hamster
urine. The advantage of using anti-HADH pAb compared
to the anti-pathogenic leptospires pAb is that the former
is more specific than the latter. Using this antiserum, the
protein (52 kDa) was successfully detected in urine after
infection (Figure 5A), and an increase in band thickness at
7–8 days post infection was confirmed by serial dilution
(Figure 5B). It seems that the appearance of 65 kDa
protein in immunoblotting (Figure 5A) was due to non-
specific reactions because normal hamster urine had the
65 kDa protein (Figure 5A) and normal rabbit serum also
reacted with such protein (data not shown). During 0–6
days after infection, urine still appeared normal and lepto-
spires were not shed in urine. Further study is needed to
identify these proteins.Hamsters and humans also have enzymes similar to
leptospiral HADH. The amino acid sequences of this
protein are conserved among Leptospira spp., however,
the amino acid homology between hamster or human and
L. interrogans serovar Copenhageni were only 25.08% or
32.44%, respectively. It is, therefore, expected that the
antisera against leptospiral HADH cannot recognize the
protein of hamsters.
Several studies previously reported that the abundant
proteins or LPS on the surface of outer membrane were
suitable as targets for vaccine and diagnosis of leptospirosis
such as outer membrane proteins [38,39], LIC11207 [40],
OmpL1 [41,42], MPL17 and MPL21 [43], HbpA [44], LigA
[45], LP29 and LP49 [46], LipL32 [47-50], LipL21 [50,51],
LipL41 [42], flagellin protein [52]. Moreover, it was also re-
ported that different proteins were expressed in leptospires
shed in chronically infected rats compared to leptospires
cultured in vitro [53], and that the leptospires in rat urine
affected urinary protein composition [54]. However, we
were not able to identify any of the previously reported
leptospiral proteins in the urine either by immunoblotting
with anti-L. interrogans pAb or MS/MS analysis. The poly-
clonal antibodies were produced in rabbits, and we
confirmed that proteins were recognized by this antibody
using immunoblotting and MS/MS analyses. The antibody
could recognize some membrane proteins such as LipL32
and LipL41 when bacterial cells were used for immuno-
blotting (unpublished data). However, leptospiral mem-
brane lipoproteins were not detected in the urine, probably
due to their low concentration. These results suggest that
not only membrane proteins but also intracellular proteins,
such as HADH, can be used as candidates for leptospirosis
diagnosis.
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urine prior to infection and a day just before death in a
hamster model, and found that the conditions drastically
changed one day prior to death. The pH of hamster urine
is usually about 8, and it was found to have become acidic
before death (Figure 1B). Urinary test results suggest that
this acidification was caused by renal failure, like nephritis.
Hamster urine is usually cloudy due to a high concentration
of calcium carbonate [55]. But, it became clear on the day
prior to death due to leptospirosis. Calcium carbonate is
deposited in alkali conditions, and dissolved in acidic condi-
tions. Leptospira-infected hamster urine was about pH 6,
and the urine remained clear even in alkaline condition in-
duced by adding sodium hydroxide. It means that the
amount of calcium carbonate excreted in urine decreased
just before the hamsters succumbed to infection. After the
seventh day of infection, viable leptospires could be recov-
ered from the urine. Thus, it is suggested that leptospires
are not shed from the kidneys until just before death.
Most of the urinary proteins detected in this study were
associated with host renal failure such as acute renal trans-
plant rejection [29,30], glomerular disease [31,32,36],
diabetes mellitus type 2 [33,35], chronic kidney disease
[34], pancreatitis [31], and endemic nephropathy [37]. The
proteins identified in our study, except for leptospiral
HADH, are biomarkers known to be involved in renal fail-
ure, but are not specific for Leptospira infection. Albumin
was the main protein detected in infected hamster urine
during the end stage of infection (Figure 2). This is one of
the plasma proteins and its primary function is to main-
tain the colloidal osmotic pressure in both the vascular
and extra-vascular spaces. The urine-excreted proteins
can serve as markers for glomerular disease [31,32] and
diabetes [33].
Conclusions
HADH was detected in urine before the onset of illness in
our hamster model of leptospirosis. This is the first study
reporting that leptospiral HADH is released in the urine
during the infection. Therefore, this protein could be ap-
plicable in early diagnostic assays for human leptospirosis.
Methods
Bacteria
Leptospira interrogans serovar Manilae strain K64 that
was isolated from the kidneys of a rat in the Philippines
[56] was used in this study, and cultured in modified
Korthof ’s medium supplemented with 10% rabbit serum
at 30°C. Prior to experiments, strain K64 was passaged
through hamsters to maintain its virulence. Strain K64
passaged less than ten times in vitro was used for experi-
ments. LD50 of strain K64 was determined by infecting
hamsters with serially diluted leptospiral suspension
[56,57]. As a result, the LD50 of K64 strain was 100.Animals
Male golden Syrian hamsters (Japan SLC, Inc., Shizuoka,
Japan), 4 weeks of age, were injected subcutaneously
with 103 low-passaged (less than 10× in vitro) leptospires
at a final volume of 1 ml Korthof ’s medium. As negative
controls, animals were injected with Korthof ’s medium
only. The urine of infected animals was collected by hous-
ing them in metabolic chambers for 6 hours daily until
they were moribund. Hamster kidneys, livers, spleens,
lungs and brains were collected aseptically and squeezed
into modified Korthof ’s medium containing 5-FU using
5 ml syringe, and incubated at 30°C [56]. Five hundred mi-
croliters of culture supernatant was sub-cultured into
fresh medium without 5-FU the next day and was kept at
30°C and examined for growth of leptospires daily for one
month. Moribund hamsters and those that survived infec-
tion after 9 days were sacrificed through inhalation with
sevoflurane (Maruishi Pharmaceutical, Japan).
All animal experiments were reviewed and approved by
the Ethics Committee on Animal Experiment at the Faculty
of Medical Sciences, Kyushu University. The experiments
were carried out following the Regulations for Animal
Experiments of Kyushu University and The Law (No. 105)
and Notification (No. 6) of the Government of Japan.
Urinalysis
The pH of hamster urine was tested using pH test paper
BTB (07010060, Advantec, Tokyo, Japan). Glucose, biliru-
bin, ketone, specific gravity, blood, protein, urobilinogen,
nitrite, and leukocyte were measured with N-MULTISTIX®
SG-L (Siemens Healthcare Diagnostics Inc., NY). The tur-
bidity of hamster urine was measured using Wallac ARVO
sx 1420 multilabel counter (Perkin Elmer, Waltham, MA,
USA) at a wavelength of 600 nm.
Pre-treatment of urine for gel electrophoresis
Due to the small amount of urine collected, urine from
three infected hamsters was pooled and used in the experi-
ments. For proteomic analysis, urine samples were first
centrifuged at 1500 × g for 10 min at 4°C to remove debris.
The supernatants were concentrated and desalted to
remove interfering substances by centrifugation at 7500 × g
for 30 min at 4°C using a centrifugal filter device (Amicon
Ultra 4 molecular mass cutoff, 10-kDa; Merck Millipore,
Billerica, MA, USA) as previously described [58]. The
desalted concentrates were stored at −20°C until further
use. Protein concentration in urine was determined using
2-D Quant Kit (GE Healthcare UK Ltd, Little Chalfont,
UK) and processed for gel electrophoresis.
Sodium dodecyl sulfide–polyacrylamide gel electrophoresis
(SDS-PAGE)
For SDS-PAGE, the concentrated and desalted urine
samples were dissolved in Laemmli sample buffer (Bio-
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beta-mercaptoethanol and incubated at 94°C for 5 min.
SDS-PAGE was performed with 10% acrylamide gels.
Electrophoresis was performed using a Mini-PROTEAN
tetra cell (Bio-Rad Laboratories, BioRad, Hercules, CA,
USA) for 120 min at 20 mA in Tris-glycine running buffer
(25 mM Tris, 192 mM glycine, 0.1% sodium dodecyl sul-
fate). Separated proteins were stained using Silver Stain
MS Kit (WAKO, Osaka, Japan).
Two dimensional electrophoresis (2-DE)
2-DE of the urine samples was analyzed using the Multi-
phor II Electrophoresis system (GE Healthcare UK Ltd,
Little Chalfont, UK) according to the manufacturer’s in-
structions with some modifications. Briefly, the desalted
urine sample was dissolved and recovered with 400 μl of
8 M urea, 4% CHAPS and 50 mM Tris/HCl (pH 8.0). Ten
mM DTT and 1% Pharmalyte, broad range pH 3–10 (GE
Healthcare UK Ltd, Little Chalfont, UK) including range
pH 4–7 were added as rehydration buffer prior to loading
for the first dimension. Samples were directly added into
the rehydration buffer and the 11 cm immobilized gradi-
ent strip (pH 4–7) was allowed to swell overnight at room
temperature. The isoelectric focusing (IEF) conditions
were as follows: (i) 1 min at a 300 V gradient, (ii) 1.5 h at a
3500 V gradient, (iii) 5 h at 3500 V, with a 50 μA per strip
maximum at 15°C. The completed first-dimensional strip
was subjected to 2-D SDS-PAGE with 12.5% acrylamide
gel. Separated proteins were stained by silver staining as
mentioned above.
Cloning and expression of recombinant HADH
A 1311-bp LIC13300 DNA fragment was amplified using
oligomers LIC13300-F 5′-GGAATTCCATATGAGAGA
AATCAAAACAGTAACAG-3′ and LIC13300-R 5′-CC
GCTCGAGTCCTTTGAAAAGTGAACGAGC-3′ desig
ned based on L. interrogans serovar Copenhageni gen-
ome sequences (GenBank accession YP_003205). PCR
was performed with KOD plus ver. 2 PCR kit (Toyobo,
Osaka, Japan) from strain K64. Cycling conditions were:
95°C, 5 min, followed by 40 cycles at 95°C, 1 min, 50°C,
1 min, 68°C, 2 min, and a final extension cycle of 5 min,
68°C. PCR product was digested with NdeI and XhoI
(Roche, Basel, Schweiz), ligated to NdeI- and XhoI-
digested expression vector, pET-28a (+) (Novagen, San
Diego, CA). The ligated plasmid was amplified in E. coli
DH5α and purified using Midi PlusTM Ultrapure Plas-
mid Extraction System (Viogene, Taipei, Taiwan). After
confirming the presence of correct inserts by sequence
analysis, the plasmid was transformed in E. coli (DE3). Cul-
tures were grown to OD600 = 0.5 and protein expression
was induced with 1 mM isopropyl-beta-D-thiogalactopy-
ranoside (IPTG), and incubated at 25°C overnight. His-
tagged LIC13300 recombinant protein (rHADH) waspurified under native conditions with TALON® Metal Af-
finity Resin (Clontech) as previously described [59].
Antiserum against rHADH
One female Japanese white rabbit (Biotek. Co.,Ltd., Japan)
weighing 1.5 kg was immunized subcutaneously with
30 μg of the recombinant protein. The rHADH was mixed
with an equal volume of complete Freund’s adjuvant
(Sigma-Aldrich, St. Louis, MO) to make an emulsion.
Four subsequent booster injections were given at two-
week intervals in the same way, by using incomplete
Freund’s adjuvant (Sigma-Aldrich, St. Louis, MO). One
week after the final immunization, the blood of rabbit was
collected through cardiac puncture and the serum was an-
alyzed by immunoblotting.
Immunoblotting
Proteins separated by SDS-PAGE were transferred to an
Immobilon-P transfer membrane (Merck Millipore, Billerica,
MA, USA) and blocked with 1% (wt/vol) nonfat dry milk
(WAKO, Osaka, Japan) in TBS-0.05% Tween 20 (TBS-T).
The membranes were incubated overnight at 4°C with
polyclonal antibody produced against live whole cells of
L. interrogans serovar Manilae (anti-L. interrogans pAb)
(1:1000 dilution) [57] or anti-HADH rabbit antiserum
polyclonal antibody (1:5000), followed by incubation for
2 h at room temperature with horseradish peroxidase
(HRP)-donkey anti-rabbit IgG conjugate (1:5000 dilution;
GE Healthcare UK Ltd, Little Chalfont, UK), or with anti-
His (C-term) mouse mAb (1:5000 dilution; Life technolo-
gies, Carlsbad, CA, USA), followed by incubation for 2 h
at room temperature with horseradish peroxidase (HRP)-
sheep anti-mouse IgG conjugate (1:10000 dilution; GE
Healthcare UK Ltd, Little Chalfont, UK). The bands were
detected with EzWest Lumi plus (ATTO, Tokyo, Japan)
and ImageQuant LAS 4000mini (GE Healthcare UK Ltd,
Little Chalfont, UK).
Liquid chromatography (LC)/mass spectrometry
(MS) analysis
Protein spots in gels were compared and analyzed by vis-
ual inspection. The gel spots were stored in 1% acetic acid
and were subjected to LC/MS/MS analysis. Identification
of proteins was carried out using Mascot server (Matrix
Science) with datasets of rodent and Leptospira pro-
teomes. A protein score of >40 was used to select proteins
with significant matching. The difference between the the-
oretical and experimental mass and pI was also used to
determine significant matching.
Additional file
Additional file 1: Table S1. Amino acid sequence coverage of
leptospiral HADH by LC/MS/MS.
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